Brief: Biotalys, Novozymes Partner To Expand Evoca's Opportunities

Biotalys NV

21/06/2022 06:04

June 21 (Reuters) - BIOTALYS NV  BTLS.BR :
    * BIOTALYS AND NOVOZYMES ENTER INTO PARTNERSHIP TO EXPAND
OPPORTUNITIES FOR EVOCA™
    * PARTNERSHIP PROVIDES THAT NOVOZYMES WILL USE ITS KNOW-HOW
TO
EXPLORE ADDITIONAL ROUTES FOR UPSCALING AND PRODUCTION OF
BIOACTIVE PROTEIN OF EVOCA
    * EVOCA IS AN INNOVATIVE PROTEIN-BASED BIOFUNGICIDE
DEVELOPED ON
BIOTALYS' AGROBODY FOUNDRY™ PLATFORM
    * EVOCA IS EXPECTED TO OBTAIN APPROVAL BY U.S. ENVIRONMENTAL
PROTECTION AGENCY (EPA) LATER THIS YEAR
    * UNDER AGREEMENT, NOVOZYMES WILL EXPLORE DURING AN INITIAL
TERM
WHETHER IT CAN UPSCALE AND PRODUCE BIOACTIVE PROTEIN OF EVOCA IN
PRODUCTION HOSTS ADDITIONAL TO THOSE CURRENTLY USED BY BIOTALYS
    * OUTCOME OF THIS FEASIBILITY STUDY CAN SERVE AS A POTENTIAL
KEY
MILESTONE FOR BIOTALYS AND NOVOZYMES TO ENTER INTO DEVELOPMENT,
SUPPLY AND COMMERCIALIZATION AGREEMENTS FOR THIS FUTURE
GENERATION OF EVOCA
    * THIS IS EXPECTED TO PAVE WAY FOR REGULATORY ASSESSMENT OF
BIOTALYS' PIPELINE OF PRODUCT CANDIDATES, WHICH INCLUDES
BIOFUNGICIDES, BIOBACTERICIDES AND BIO-INSECTICIDES BASED ON
BIOTALYS AGROBODY FOUNDRY TECHNOLOGY PLATFORM

Source text for Eikon:  ID:nGNE38Mtxd 
Further company coverage:  BTLS.BR   NZYMb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))